Clearing Up Confusion about the Medicaid Rebate Program: Part I
As federal efforts to address prescription drug costs intensify, this three-part blog series addresses misleading claims or confusion about Medicaid, its highly effective drug rebate program and overall drug pricing issues in the hopes of better informing the debate moving forward. Part II | Part III In response to federal Medicaid rebate increases, drug manufacturers would […]